Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases

Antiphospholipid syndrome (APS) is a rare autoimmune disease characterized by thromboses at various sites and obstetric events associated with the persistent presence of antiphospholipid antibodies. The identification of clinical phenotypes in APS patients is a clinical need. In this study, we aimed...

Full description

Saved in:
Bibliographic Details
Published in:Journal of autoimmunity 2024-04, Vol.144, p.103173-103173, Article 103173
Main Authors: Taieb, Dov, Moyon, Quentin, Lhote, Raphael, Annesi-Maesano, Isabella, Haroche, Julien, Cervera, Ricard, Amoura, Zahir, Cohen Aubart, Fleur
Format: Article
Language:English
Subjects:
Antibodies, Antiphospholipid
Antiphospholipid
Antiphospholipid Syndrome
Female
Humans
Phenotype
Phenotypes
Pregnancy
Stroke
Thrombosis
Venous Thrombosis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Antiphospholipid syndrome (APS) is a rare autoimmune disease characterized by thromboses at various sites and obstetric events associated with the persistent presence of antiphospholipid antibodies. The identification of clinical phenotypes in APS patients is a clinical need. In this study, we aimed to determine the clinical phenotypes of APS patients through an unsupervised analysis of two well-characterized cohorts of APS patients. APS phenotypes were defined by an ascending hierarchical cluster analysis to identify preferential associations between 18 types of organ involvement and clinical characteristics. This analysis was performed on an initial multi-center cohort of 1000 patients, with validation in a replication cohort of 435 patients. The hierarchical analysis identified three APS phenotypes in both the initial and replication cohorts: an obstetric phenotype (n = 259 and n = 74 patients, respectively), a venous thrombosis phenotype, accounting for the largest number of patients (n = 461 and n = 297 patients, respectively), and a skin-central nervous system-heart phenotype (n = 280 and n = 64 patients, respectively). The clinical characteristics of the patients differed significantly between the three phenotypes, but there was no difference in antiphospholipid antibody profile between the groups. We identified three phenotypes of APS defined based on preferential associations of organ involvements and differences in presentation. These observations may help clinicians to detect organ involvement and to manage treatment. •Highlights “Phenotypes in antiphospholipid syndrome: a hierarchical cluster analysis based on two independent databases“.•Three phenotypes of Antiphospholipid Syndrome defined based on preferential associations of organ involvements.•By performing an analysis on an initial cohort of 1000 patients, with validation in a replication cohort of 435 patients.•These results may help clinicians to detect organ involvement and to manage treatment.
ISSN:0896-8411
1095-9157
DOI:10.1016/j.jaut.2024.103173